Suppr超能文献

一种用于SAMHD1脱氧核苷酸三磷酸酶的高通量酶联测定法。

A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase.

作者信息

Seamon Kyle J, Stivers James T

机构信息

Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

出版信息

J Biomol Screen. 2015 Jul;20(6):801-9. doi: 10.1177/1087057115575150. Epub 2015 Mar 9.

Abstract

Sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) is a recently discovered enzyme that plays a central role in nucleotide metabolism and innate immunity. SAMHD1 has deoxyribonucleoside triphosphate (dNTP) triphosphohydrolase activity that depletes the dNTP substrates required for DNA synthesis in cells. The involvement of SAMHD1 in biological processes as varied as viral restriction, endogenous retroelement control, cancer, and modulation of anticancer/antiviral nucleoside drug efficacy makes it a valuable target for the development of small-molecule inhibitors. We report a high-throughput colorimetric assay for SAMHD1 dNTP hydrolase activity that takes advantage of Escherichia coli inorganic pyrophosphatase to convert PPPi to 3 Pi. The assay was validated by screening a library of 2653 clinically used compounds. Fifteen primary hits were obtained (0.57% hit rate); 80% of these were confirmed in a direct secondary assay for dNTP hydrolysis. The zinc salt of the antibiotic cephalosporin C was a potent inhibitor of SAMHD1 with an IC50 of 1.1 ± 0.1 µM, and this inhibition was largely attributable to the presence of zinc. The assay also screened a targeted library of nucleosides and their analogs, revealing that the antiviral drug acycloguanosine (acyclovir) is an inhibitor possessing excellent properties for future fragment-based drug development efforts.

摘要

含 sterile alpha 基序和组氨酸 - 天冬氨酸结构域蛋白 1(SAMHD1)是一种最近发现的酶,在核苷酸代谢和固有免疫中起核心作用。SAMHD1 具有脱氧核糖核苷三磷酸(dNTP)三磷酸水解酶活性,可消耗细胞中 DNA 合成所需的 dNTP 底物。SAMHD1 参与多种生物过程,如病毒限制、内源性逆转录元件控制、癌症以及抗癌/抗病毒核苷药物疗效的调节,这使其成为开发小分子抑制剂的有价值靶点。我们报告了一种用于 SAMHD1 dNTP 水解酶活性的高通量比色测定法,该方法利用大肠杆菌无机焦磷酸酶将焦磷酸(PPPi)转化为 3 个磷酸根离子(Pi)。通过筛选一个包含 2653 种临床使用化合物的文库对该测定法进行了验证。获得了 15 个初步命中物(命中率为 0.57%);其中 80%在 dNTP 水解的直接二级测定中得到证实。抗生素头孢菌素 C 的锌盐是 SAMHD1 的有效抑制剂,IC50 为 1.1±0.1μM,这种抑制作用很大程度上归因于锌的存在。该测定法还筛选了一个核苷及其类似物的靶向文库,结果表明抗病毒药物阿昔洛韦(acyclovir)是一种具有优异特性的抑制剂,适用于未来基于片段的药物开发研究。

相似文献

1
A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase.
J Biomol Screen. 2015 Jul;20(6):801-9. doi: 10.1177/1087057115575150. Epub 2015 Mar 9.
2
Identification of Inhibitors of the dNTP Triphosphohydrolase SAMHD1 Using a Novel and Direct High-Throughput Assay.
Biochemistry. 2018 Nov 27;57(47):6624-6636. doi: 10.1021/acs.biochem.8b01038. Epub 2018 Nov 13.
3
Deoxyguanosine-Linked Bifunctional Inhibitor of SAMHD1 dNTPase Activity and Nucleic Acid Binding.
ACS Chem Biol. 2023 Oct 20;18(10):2200-2210. doi: 10.1021/acschembio.3c00118. Epub 2023 May 26.
5
SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity.
Nucleic Acids Res. 2015 Jul 27;43(13):6486-99. doi: 10.1093/nar/gkv633. Epub 2015 Jun 22.
7
Small molecule inhibition of SAMHD1 dNTPase by tetramer destabilization.
J Am Chem Soc. 2014 Jul 16;136(28):9822-5. doi: 10.1021/ja5035717. Epub 2014 Jul 8.
8

引用本文的文献

1
Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir.
Biochemistry. 2025 Mar 4;64(5):1109-1120. doi: 10.1021/acs.biochem.4c00854. Epub 2025 Feb 24.
2
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel.
iScience. 2024 Jan 13;27(2):108907. doi: 10.1016/j.isci.2024.108907. eCollection 2024 Feb 16.
3
Deoxyguanosine-Linked Bifunctional Inhibitor of SAMHD1 dNTPase Activity and Nucleic Acid Binding.
ACS Chem Biol. 2023 Oct 20;18(10):2200-2210. doi: 10.1021/acschembio.3c00118. Epub 2023 May 26.
4
Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease.
Acta Pharmacol Sin. 2023 Apr;44(4):791-800. doi: 10.1038/s41401-022-01002-5. Epub 2022 Oct 13.
6
Targeting the DNA damage response and repair in cancer through nucleotide metabolism.
Mol Oncol. 2022 Nov;16(21):3792-3810. doi: 10.1002/1878-0261.13227. Epub 2022 May 28.
7
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.
J Exp Clin Cancer Res. 2021 Oct 12;40(1):317. doi: 10.1186/s13046-021-02093-4.
8
Probing the Catalytic Mechanism and Inhibition of SAMHD1 Using the Differential Properties of R- and S-dNTPαS Diastereomers.
Biochemistry. 2021 Jun 1;60(21):1682-1698. doi: 10.1021/acs.biochem.0c00944. Epub 2021 May 14.
9
Dual roles of SAMHD1 in tumor development and chemoresistance to anticancer drugs.
Oncol Lett. 2021 Jun;21(6):451. doi: 10.3892/ol.2021.12712. Epub 2021 Apr 8.
10
Spectral Unmixing-Based Reaction Monitoring of Transformations between Nucleosides and Nucleobases.
Chembiochem. 2020 Sep 14;21(18):2604-2610. doi: 10.1002/cbic.202000204. Epub 2020 Jun 18.

本文引用的文献

1
A continuous enzyme-coupled assay for triphosphohydrolase activity of HIV-1 restriction factor SAMHD1.
Antimicrob Agents Chemother. 2015 Jan;59(1):186-92. doi: 10.1128/AAC.03903-14. Epub 2014 Oct 20.
2
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction.
Nat Med. 2014 Aug;20(8):936-41. doi: 10.1038/nm.3626. Epub 2014 Jul 20.
3
Small molecule inhibition of SAMHD1 dNTPase by tetramer destabilization.
J Am Chem Soc. 2014 Jul 16;136(28):9822-5. doi: 10.1021/ja5035717. Epub 2014 Jul 8.
4
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors.
Antimicrob Agents Chemother. 2014 Aug;58(8):4915-9. doi: 10.1128/AAC.02745-14. Epub 2014 May 27.
5
GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state.
Proc Natl Acad Sci U S A. 2014 May 6;111(18):E1843-51. doi: 10.1073/pnas.1401706111. Epub 2014 Apr 21.
6
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.
Nature. 2014 Jan 23;505(7484):509-14. doi: 10.1038/nature12940.
7
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
Blood. 2014 Feb 13;123(7):1021-31. doi: 10.1182/blood-2013-04-490847. Epub 2013 Dec 12.
9
Mechanism of allosteric activation of SAMHD1 by dGTP.
Nat Struct Mol Biol. 2013 Nov;20(11):1304-9. doi: 10.1038/nsmb.2692. Epub 2013 Oct 20.
10
Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sézary syndrome patients.
J Invest Dermatol. 2014 Feb;134(2):562-565. doi: 10.1038/jid.2013.311. Epub 2013 Jul 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验